Treatment of experimental Legionnaires' disease by aerosol administration of rifampicin, ciprofloxacin, and erythromycin.
Fitzgeorge
R B
RB
Baskerville
A
A
Featherstone
A S
AS
D000336:Aerosols; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002939:Ciprofloxacin; D004917:Erythromycin / Q000008:administration & dosage*; D006168:Guinea Pigs; D007875:Legionella / Q000187:drug effects; D007877:Legionnaires' Disease / Q000188:drug therapy*; D008168:Lung / Q000382:microbiology; D011804:Quinolines / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage*
D000336:Aerosols; D000900:Anti-Bacterial Agents; D011804:Quinolines; D002939:Ciprofloxacin; D004917:Erythromycin; D012293:Rifampin